Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030087

Enrollment

Unknown

Registered

2020-02-22

Start date

2020-02-12

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The COVID-19 patients are confirmed according to the novel coronavirus pneumonia diagnosis and treatment plan (trial version fifth) issued by the National Health Protection Commission and the Chinese medicine administration.

Exclusion criteria

Exclusion criteria: 1. Previous cheset trauma and surgery; 2. Previous severe emphysema and chronic obstructive pulmonary disease.

Design outcomes

Primary

Measure	Time frame
Three-dimensional ultrasound;Two-dimensional ultrasound;Respiration related parameters;Doppler ultrasound;	—

Countries

China

Contacts

Public ContactMingxing Xie

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

xiemx@hust.edu.cn+86 13607108938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026